ENAH ‐202 promotes cancer progression in oral squamous cell carcinoma by regulating ZNF502 / VIM axis
Cancer Medicine · 2023
DOI: 10.1002/cam4.6652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Xinyue Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Weifang Medical University, Weifang, Shandong, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2021 Youth Innovation Talent Introduction and Education Program of Shandong Province Universities, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
We aimed to demonstrate the regulatory effect of long non‐coding RNA (lncRNA) ENAH‐202 on oral squamous cell carcinoma (OSCC) development as well as its molecular mechanism.
Methods
We detected ENAH‐202 expression in OSCC tissues and cell lines by quantitative real‐time PCR (qPCR). The biological function of ENAH‐202 was assessed in vitro and in vivo using CCK‐8, colony formation assays, transwell assays, xenograft formation, and tail vein injection. The further molecular mechanism by which ENAH‐202 promoted OSCC progression was identified using RNA pull‐down, LS‐MS/MS analysis, RNA immunoprecipitation (RIP), and chromatin immunoprecipitation (ChIP) assays.
Results
ENAH‐202 was significantly upregulated in OSCC tissues and cells. ENAH‐202 promoted OSCC cell proliferation, migration, and invasion in vitro and in vivo. The expression of enabled homolog (ENAH) and epithelial‐to‐mesenchymal transition (EMT)‐related proteins was changed with the expression of ENAH‐202. Moreover, ENAH‐202 promoted the transcription of Vimentin (VIM) by binding with ZNF502, which can help ENAH‐202 promote OSCC progression.
Conclusions
ENAH‐202 facilitated OSCC cell proliferation and metastasis by regulating ZNF502/VIM axis, which played an important role in OSCC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Stomatology, Weifang Medical University, Weifang, Shandong, China.
- Weifang Key Laboratory of Oral Biomedicine, Weifang Medical University, Weifang, Shandong, China.
ORCID-Profile: Yingying Jiang
Förderung
- 2021 Youth Innovation Talent Introduction and Education Program of Shandong Province Universities
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- National Facility for Translational Medicine (Shanghai)
Zitieren
APA
Zhang, X., Chen, X., Sun, D., Song, N., Li, M., Zheng, W., Yu, Y., Ding, G., & Jiang, Y. (2023). ENAH ‐202 promotes cancer progression in oral squamous cell carcinoma by regulating ZNF502 / VIM axis. Cancer Medicine. https://doi.org/10.1002/cam4.6652
Vancouver
Zhang X, Chen X, Sun D, Song N, Li M, Zheng W, et al. ENAH ‐202 promotes cancer progression in oral squamous cell carcinoma by regulating ZNF502 / VIM axis. Cancer Medicine. 2023. doi:10.1002/cam4.6652
BibTeX
@article{Zhang2023,
author = {Zhang, Xinyue and Chen, Xi and Sun, Dongyuan and Song, Ning and Li, Minmin and Zheng, Wentian and Yu, Yang and Ding, Gang and Jiang, Yingying},
title = {ENAH ‐202 promotes cancer progression in oral squamous cell carcinoma by regulating ZNF502 / VIM axis},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6652}
}
EUVIMED